LucaNJYeungRS. Epidemiology and management of Kawasaki disease. Drugs. 2012;72:1029-1038.
2.
KimDS. Kawasaki disease. Yonsei Med J. 2006;47:759-772.
3.
Gámez-GonzálezLBMurataCMuñoz-RamírezMYamazaki-NakashimadaM. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr. 2013;172:337-342.
4.
KanegayeJTWilderMSMolkaraD. Recognition of Kawasaki disease shock syndrome. Pediatrics. 2009;123:e783-e789.
5.
LinM-TFuC-MHuangS-KHuangS-CWuM-H. Population-based study of Kawasaki disease shock syndrome in Taiwan. Pediatr Infect Dis J. 2013;32:1384-1386.
6.
ChenP-SChiHHuangF-YPengC-CChenM-RChiuN-C. Clinical manifestations of Kawasaki disease shock syndrome: a case-control study [published online August 7, 2013]. J Microbiol Immunol Infect. doi:10.1016/j.jmii.2013.06.005.
7.
ThabetFBafaqihHAl-MohaimeedSAl-HilaliMAl-SewairiWChehabM. Shock: an unusual presentation of Kawasaki disease. Eur J Pediatr. 2011;170:941-943.
8.
Ibáñez-AlcaldeMSánchez-ForteMGiménez-SánchezFOrtega-MontesÁMartínez-EspinosaG. Cholestasis as the initial feature of Kawasaki disease. Pediatr Infect Dis J. 2012;31:766-767.
9.
AlvesNRMagalhãesCMAlmeida RdeFSantosRCGandolfiLPratesiR. Prospective study of Kawasaki disease complications: review of 115 cases. Rev Assoc Med Bras. 2011;57:295-300.
10.
FradinKNRhimHJ. An adolescent with fever, jaundice and abdominal pain: an unusual presentation of Kawasaki disease. J Adolesc Health. 2013;52:131-133.